Those with a finger on the pulse of the US Drug Supply Chain Security Act (DSCSA) will have heard from all rooftops by now that FDA has granted all pharmaceutical Trading Partners a 12-month Stabilization Period. If […]
This is a brief animated summary of one of my own blog articles. It explains why trusted issuer lists are important for electronic credential verification. Music: “Francisco” by Michael Ramir C. (https://mixkit.co/free-stock-music/rock/) Find even more background info […]
Spherity has developed an Ethereum-based credential revocation mechanism for use in the US pharmaceutical supply chain I have previously written about the importance of managing a registry of trusted issuers in the context of enterprise Self-sovereign Identity (SSI). A […]
So, here I was – a non-techie and SSI noob at a week-long expert geek event. What on earth was I going to do during the next 5 days?!
DSCSA concerns 60,000 U.S. pharmaceutical supply chain actors. I presented how Spherity’s compliance app for Authorized Trading Partners (ATP) provides a solution for regulatory compliance. Watch the recording to learn more. Even if you’re not in pharma, this […]
My presentation at the eIDAS Summit 2022 on Spherity’s DSCSA solution for Authorized Trading Partners (ATP) in the US pharmaceutical supply chain. Even if you’re not in pharma, this is a great example for the real-world application […]